Iminodiacetic Acid as a Novel Metal-binding Pharmacophore for New Delhi Metallo-b-lactamase Inhibitor Development .
2020
The fungal natural product Aspergillomarasmine A (AMA) has been identified as a non-competitive inhibitor of New Delhi Metallo-β-lactamase-1 (NDM-1) that inhibits via active site Zn(II) removal. The non-selective metal-chelating properties and the difficult synthesis and derivatization of AMA have hindered the development of this scaffold into a potent and selective inhibitor of NDM-1. Iminodiacetic acid ( IDA ) has been identified as the metal-binding pharmacophore (MBP) core of AMA that can be leveraged for inhibitor development. Herein, we report the utilization of IDA for the fragment-based drug discovery (FBDD) of NDM-1 inhibitors. IDA (IC50 = 122 μM) was developed into inhibitor 23f (IC50 = 8.6 μM, K i = 2.6 μM) and displayed the formation of a ternary complex with NDM-1, as evidenced by protein thermal shift and native state electrospray ionization mass spectrometry (ESI-MS) experiments. Combining mechanistic analysis in tandem with inhibitor derivatization, the potential for utilizing the IDA NDM-1 inhibitor development is detailed. .
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
66
References
7
Citations
NaN
KQI